key: cord-0937192-5qmaj7pk
authors: Marin-Corral, J.; Pascual-Guardia, S.; Muñoz-Bermúdez, R.; Salazar-Degracia, A.; Climent, C.; Vilà, C.; Acer, M.; Picornell, M.; Restrepo, MI; Masclans, JR; Álvarez-Lerma, F.
title: Health care-associated infections in patients with COVID-19 pneumonia in COVID critical care areas
date: 2021-04-30
journal: Med Intensiva
DOI: 10.1016/j.medin.2021.04.003
sha: 13b097ac2fdac923a6084cdab099ea4c6e11ff3c
doc_id: 937192
cord_uid: 5qmaj7pk

nan

The first wave of the COVID-19 pandemic challenged health systems worldwide. Its high capacity to generate critical patients required rapid expansion of beds beyond the classical intensive care unit (ICU) to other spaces termed "expanded ICU (eICU)", as well as repurposing and redistribution of resources, personnel from other areas and specialised personnel. This new situation made it more difficult to comply with the recommendations for prevention of health care-associated infections (HAIs) what added to the higher exposition of patients to immunosuppressive treatments or requiring long ICU stays, made them more susceptible to HAIs. Several studies have shown higher rates of HAIs in COVID-19, but none of them as a principal factor in critically ill patients (1) (2) (3) (4) (5) (6) (7) (8) .

Our aims were to determine the rates, aetiology, risk factors and impact of HAIs diagnosed in critically ill patients with COVID-19 pneumonia admitted to the different COVID-19 ICUs. It is a retrospective, observational, single-centre study. We evaluated all nosocomial bacteraemias (bloodstream infeccions or BSI), urinary tract (UTI), respiratory (VLRTI), pressure ulcer (IPU) and tracheostomy site infections (TSI) in patients with COVID-19 pneumonia admitted to one COVID-19 ICU (principal ICU or one of our 3 eICUs). The HAI incidence rates (IR) were analysed according to the patients' location. Risk factors for HAI were identified from multivariate analysis. ICU length of stay (LOS) and mortality were analysed according to the number of HAIs (0, 1, 2, or ≥3). More details are shown in the online supplemental material. Table 2e ). Of all the causative organisms isolated, 18.4% were MDR (Table 3e) Among the microorganisms identified as causing HAIs, many were part of the primary and secondary endogenous microflora (species of Candida, Enterococcus and enterobacterales, in particular K. pneumoniae) while those associated with cross transmission or reservoirs were less common. Endogenous flora was particularly common in UTIs and primary bacteraemias, suggesting spread from the gut flora. In contrast, P. aeruginosa, the most prevalent pathogen in our hospital for colonisation or nosocomial infection was associated with cross transmission particularly in patients who developed VLRTIs. Surprisingly, the presence of MDR pathogens was low and heterogeneous, and there were no identified outbreaks.

Total ICU LOS conditioned the development of HAIs. Patients who developed one or more HAIs had longer total ICU LOS, although in most cases ICU LOS prior to HAI and total ICU LOS in patients without HAI were similar. Presence of HAI and total number of HAIs per patient were associated with higher ICU mortality. Unfortunately, 20% of patients who died in the ICU had a diagnosis of HAI within 72 hours of death.

In conclusion, the high rates of HAI, the differences observed between the main ICU and the three expanded units, the movement of patients between ICUs and the significant clinical impact and use of resources indicate that we must plan specific interventions to minimise such patterns in future pandemics and epidemics. 

Patient characteristics, cinical course and factors associated to ICU mortality in critically ill patients infected with SARS-CoV-2 in Spain: a prospective, cohort, multicentre study

High rate of infections during ICU admission of patients with severe SARS-COV-2 pneumonia: a matter of time?

Co-infections in people with COVID-19: a systematic review and meta-analysis

Bacterial and viral co-infections in patients with severe SARS-CoV-2 pneumonia admitted to a French ICU

Co-infections in COVID-19 critically ill and antibiotic management: a prospective cohort analysis

Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study

Characterization and clinical course of 1000 patients with COVID-19 in New York: retrospective case series

Plan de desescalada para los servicios de medicina intensiva tras la pandemia producida por la COVID-19

Risk factors and outcome of nosocomial infections: results of a matched case-control study of ICU patients

Nosocomial infections in the intensive care unit: Incidence, risk factors, outcome and associated pathogens in a public tertiary teaching hospital of Eastern India

Hospital-acquired infections in the adult intensive care unit-Epidemiology, antimicrobial resistance patterns, and risk factors for acquisition and mortality